United States Breaking News

X-Bow Systems announced that it was selected by Leidos (NYSE:LDOS) to develop and manufacture solid rocket motor booster systems for the U.S. Army’s Low-Cost Containerized Munition (LCCM) program.

Dot Ai (NASDAQ:DAIC) completed the acquisition of Envoy Technologies from BladeRanger through an all-stock transaction valued at approximately $65 million, using common stock and Series C Convertible Preferred Stock based on an agreed $6 reference price.

Flyte Aviation (NASDAQ:VJET) reported preliminary third-quarter 2026 revenue of approximately $2.15 million, compared with $1.02 million in the second quarter of 2026.

Enovix (NASDAQ:ENVX) reported preliminary Q3 2026 revenue of approximately $11 million, compared with company guidance of $9 million to $10 million, while revenue increased from the prior-year period.

Bristol Myers Squibb (NYSE:BMY) announced topline results from the planned interim analysis of the Phase 3 ACTION-1 trial evaluating RYZ101 (225Ac-DOTATATE) in patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

First Tracks Biotherapeutics (NASDAQ:TRAX) reported Phase 1b results for ANB033, showing statistically significant changes in intestinal damage and immune-cell measurements during a gluten-challenge study in patients with celiac disease.

As the war in Ukraine enters nears its fifth year, Dutch Defense Minister Dilan Yesilgoz-Zegerius says "it's very important to make sure that the sanctions" against Russia remain in place, so that Russian President Vladimir "doesn't get everything he needs to fund this war." She made the comments in an interview with Bloomberg Television from the Warsaw Security Forum on Monday.

Kratos Defense & Security Solutions (NASDAQ:KTOS) and Airbus completed the first European test flight of the U740-Valkyrie uncrewed combat aircraft, with the flight meeting planned objectives including autonomous flight operations and mission adjustments.

HSBC will phase out fixed-pay allowances for its senior staff and instead hand out a greater proportion of its compensation in the form of bonuses, becoming the latest UK lender to switch to Wall Street-style remuneration to better align with performance. Bloomberg's finance reporter, Harry Wilson, reports on The Pulse.

Bristol Myers Squibb (NYSE:BMY) announced topline results from the Phase 3 ALOFT-IPF trial, where admilparant demonstrated a statistically significant improvement in absolute change in forced vital capacity (FVC) from baseline to Week 52 compared with placebo at the 60 mg dose.

Amrita Sen, founder and director of market intelligence at Energy Aspects, discusses what she calls "extremely desperate measures" by US President Donald Trump to increase Moscow's diesel sales into global markets and the announcement of an "energy ceasefire" between Russia and Ukraine. She speaks on "Bloomberg Surveillance."

Lazard (NYSE:LAZ) reported preliminary unaudited assets under management of $284,029 million as of September 30, 2026, compared with $290,332 million on August 31, 2026.